[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Viral Vaccines Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

January 2024 | 118 pages | ID: GE6BE00670F0EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Viral Vaccines market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Viral Vaccines market are covered in Chapter 9:

Pfizer, Inc.

Sanofi

Merck & Co., Inc.

AstraZeneca plc

Seqirus (CSL Limited)

Novavax, Inc.

GlaxoSmithKline plc

Novartis, Inc.

Serum institute of India Private Limited

Emergent BioSolutions Inc.

In Chapter 5 and Chapter 7.3, based on types, the Viral Vaccines market from 2017 to 2027 is primarily split into:

Attenuated Vaccine

Inactivated Vaccine

In Chapter 6 and Chapter 7.4, based on applications, the Viral Vaccines market from 2017 to 2027 covers:

Hospital

Clinics

Physician's Office

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Viral Vaccines market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Viral Vaccines Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027
1 VIRAL VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Viral Vaccines Market
1.2 Viral Vaccines Market Segment by Type
  1.2.1 Global Viral Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Viral Vaccines Market Segment by Application
  1.3.1 Viral Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Viral Vaccines Market, Region Wise (2017-2027)
  1.4.1 Global Viral Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.3 Europe Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.4 China Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.5 Japan Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.6 India Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.8 Latin America Viral Vaccines Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Viral Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Viral Vaccines (2017-2027)
  1.5.1 Global Viral Vaccines Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Viral Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Viral Vaccines Market

2 INDUSTRY OUTLOOK

2.1 Viral Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Viral Vaccines Market Drivers Analysis
2.4 Viral Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Viral Vaccines Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Viral Vaccines Industry Development

3 GLOBAL VIRAL VACCINES MARKET LANDSCAPE BY PLAYER

3.1 Global Viral Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global Viral Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global Viral Vaccines Average Price by Player (2017-2022)
3.4 Global Viral Vaccines Gross Margin by Player (2017-2022)
3.5 Viral Vaccines Market Competitive Situation and Trends
  3.5.1 Viral Vaccines Market Concentration Rate
  3.5.2 Viral Vaccines Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL VIRAL VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Viral Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Viral Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Viral Vaccines Market Under COVID-19
4.5 Europe Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Viral Vaccines Market Under COVID-19
4.6 China Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Viral Vaccines Market Under COVID-19
4.7 Japan Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Viral Vaccines Market Under COVID-19
4.8 India Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Viral Vaccines Market Under COVID-19
4.9 Southeast Asia Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Viral Vaccines Market Under COVID-19
4.10 Latin America Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Viral Vaccines Market Under COVID-19
4.11 Middle East and Africa Viral Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Viral Vaccines Market Under COVID-19

5 GLOBAL VIRAL VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Viral Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Viral Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global Viral Vaccines Price by Type (2017-2022)
5.4 Global Viral Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Viral Vaccines Sales Volume, Revenue and Growth Rate of Attenuated Vaccine (2017-2022)
  5.4.2 Global Viral Vaccines Sales Volume, Revenue and Growth Rate of Inactivated Vaccine (2017-2022)

6 GLOBAL VIRAL VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Global Viral Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global Viral Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Viral Vaccines Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Viral Vaccines Consumption and Growth Rate of Hospital (2017-2022)
  6.3.2 Global Viral Vaccines Consumption and Growth Rate of Clinics (2017-2022)
  6.3.3 Global Viral Vaccines Consumption and Growth Rate of Physician's Office (2017-2022)
  6.3.4 Global Viral Vaccines Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL VIRAL VACCINES MARKET FORECAST (2022-2027)

7.1 Global Viral Vaccines Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Viral Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Viral Vaccines Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Viral Vaccines Price and Trend Forecast (2022-2027)
7.2 Global Viral Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Viral Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Viral Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Viral Vaccines Revenue and Growth Rate of Attenuated Vaccine (2022-2027)
  7.3.2 Global Viral Vaccines Revenue and Growth Rate of Inactivated Vaccine (2022-2027)
7.4 Global Viral Vaccines Consumption Forecast by Application (2022-2027)
  7.4.1 Global Viral Vaccines Consumption Value and Growth Rate of Hospital(2022-2027)
  7.4.2 Global Viral Vaccines Consumption Value and Growth Rate of Clinics(2022-2027)
  7.4.3 Global Viral Vaccines Consumption Value and Growth Rate of Physician's Office(2022-2027)
  7.4.4 Global Viral Vaccines Consumption Value and Growth Rate of Others(2022-2027)
7.5 Viral Vaccines Market Forecast Under COVID-19

8 VIRAL VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Viral Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Viral Vaccines Analysis
8.6 Major Downstream Buyers of Viral Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Viral Vaccines Industry

9 PLAYERS PROFILES

9.1 Pfizer, Inc.
  9.1.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Viral Vaccines Product Profiles, Application and Specification
  9.1.3 Pfizer, Inc. Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Sanofi
  9.2.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Viral Vaccines Product Profiles, Application and Specification
  9.2.3 Sanofi Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Merck & Co., Inc.
  9.3.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Viral Vaccines Product Profiles, Application and Specification
  9.3.3 Merck & Co., Inc. Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 AstraZeneca plc
  9.4.1 AstraZeneca plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Viral Vaccines Product Profiles, Application and Specification
  9.4.3 AstraZeneca plc Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Seqirus (CSL Limited)
  9.5.1 Seqirus (CSL Limited) Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Viral Vaccines Product Profiles, Application and Specification
  9.5.3 Seqirus (CSL Limited) Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Novavax, Inc.
  9.6.1 Novavax, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Viral Vaccines Product Profiles, Application and Specification
  9.6.3 Novavax, Inc. Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 GlaxoSmithKline plc
  9.7.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Viral Vaccines Product Profiles, Application and Specification
  9.7.3 GlaxoSmithKline plc Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Novartis, Inc.
  9.8.1 Novartis, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Viral Vaccines Product Profiles, Application and Specification
  9.8.3 Novartis, Inc. Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Serum institute of India Private Limited
  9.9.1 Serum institute of India Private Limited Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Viral Vaccines Product Profiles, Application and Specification
  9.9.3 Serum institute of India Private Limited Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Emergent BioSolutions Inc.
  9.10.1 Emergent BioSolutions Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Viral Vaccines Product Profiles, Application and Specification
  9.10.3 Emergent BioSolutions Inc. Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Viral Vaccines Product Picture

Table Global Viral Vaccines Market Sales Volume and CAGR (%) Comparison by Type

Table Viral Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Viral Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Viral Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Viral Vaccines Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Viral Vaccines Industry Development

Table Global Viral Vaccines Sales Volume by Player (2017-2022)

Table Global Viral Vaccines Sales Volume Share by Player (2017-2022)

Figure Global Viral Vaccines Sales Volume Share by Player in 2021

Table Viral Vaccines Revenue (Million USD) by Player (2017-2022)

Table Viral Vaccines Revenue Market Share by Player (2017-2022)

Table Viral Vaccines Price by Player (2017-2022)

Table Viral Vaccines Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Viral Vaccines Sales Volume, Region Wise (2017-2022)

Table Global Viral Vaccines Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Viral Vaccines Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Viral Vaccines Sales Volume Market Share, Region Wise in 2021

Table Global Viral Vaccines Revenue (Million USD), Region Wise (2017-2022)

Table Global Viral Vaccines Revenue Market Share, Region Wise (2017-2022)

Figure Global Viral Vaccines Revenue Market Share, Region Wise (2017-2022)

Figure Global Viral Vaccines Revenue Market Share, Region Wise in 2021

Table Global Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Viral Vaccines Sales Volume by Type (2017-2022)

Table Global Viral Vaccines Sales Volume Market Share by Type (2017-2022)

Figure Global Viral Vaccines Sales Volume Market Share by Type in 2021

Table Global Viral Vaccines Revenue (Million USD) by Type (2017-2022)

Table Global Viral Vaccines Revenue Market Share by Type (2017-2022)

Figure Global Viral Vaccines Revenue Market Share by Type in 2021

Table Viral Vaccines Price by Type (2017-2022)

Figure Global Viral Vaccines Sales Volume and Growth Rate of Attenuated Vaccine (2017-2022)
Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate of Attenuated Vaccine (2017-2022)
Figure Global Viral Vaccines Sales Volume and Growth Rate of Inactivated Vaccine (2017-2022)
Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccine (2017-2022)
Table Global Viral Vaccines Consumption by Application (2017-2022)

Table Global Viral Vaccines Consumption Market Share by Application (2017-2022)

Table Global Viral Vaccines Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Viral Vaccines Consumption Revenue Market Share by Application (2017-2022)

Table Global Viral Vaccines Consumption and Growth Rate of Hospital (2017-2022)
Table Global Viral Vaccines Consumption and Growth Rate of Clinics (2017-2022)
Table Global Viral Vaccines Consumption and Growth Rate of Physician's Office (2017-2022)
Table Global Viral Vaccines Consumption and Growth Rate of Others (2017-2022)
Figure Global Viral Vaccines Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Viral Vaccines Price and Trend Forecast (2022-2027)

Figure USA Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Viral Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Viral Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Viral Vaccines Market Sales Volume Forecast, by Type

Table Global Viral Vaccines Sales Volume Market Share Forecast, by Type

Table Global Viral Vaccines Market Revenue (Million USD) Forecast, by Type

Table Global Viral Vaccines Revenue Market Share Forecast, by Type

Table Global Viral Vaccines Price Forecast, by Type

Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate of Attenuated Vaccine (2022-2027)
Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate of Attenuated Vaccine (2022-2027)
Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccine (2022-2027)
Figure Global Viral Vaccines Revenue (Million USD) and Growth Rate of Inactivated Vaccine (2022-2027)
Table Global Viral Vaccines Market Consumption Forecast, by Application

Table Global Viral Vaccines Consumption Market Share Forecast, by Application

Table Global Viral Vaccines Market Revenue (Million USD) Forecast, by Application

Table Global Viral Vaccines Revenue Market Share Forecast, by Application

Figure Global Viral Vaccines Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Viral Vaccines Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Viral Vaccines Consumption Value (Million USD) and Growth Rate of Physician's Office (2022-2027)
Figure Global Viral Vaccines Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Viral Vaccines Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Pfizer, Inc. Profile
Table Pfizer, Inc. Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Viral Vaccines Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Viral Vaccines Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Viral Vaccines Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca plc Profile
Table AstraZeneca plc Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca plc Viral Vaccines Sales Volume and Growth Rate
Figure AstraZeneca plc Revenue (Million USD) Market Share 2017-2022
Table Seqirus (CSL Limited) Profile
Table Seqirus (CSL Limited) Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Seqirus (CSL Limited) Viral Vaccines Sales Volume and Growth Rate
Figure Seqirus (CSL Limited) Revenue (Million USD) Market Share 2017-2022
Table Novavax, Inc. Profile
Table Novavax, Inc. Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novavax, Inc. Viral Vaccines Sales Volume and Growth Rate
Figure Novavax, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline plc Viral Vaccines Sales Volume and Growth Rate
Figure GlaxoSmithKline plc Revenue (Million USD) Market Share 2017-2022
Table Novartis, Inc. Profile
Table Novartis, Inc. Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis, Inc. Viral Vaccines Sales Volume and Growth Rate
Figure Novartis, Inc. Revenue (Million USD) Market Share 2017-2022
Table Serum institute of India Private Limited Profile
Table Serum institute of India Private Limited Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Serum institute of India Private Limited Viral Vaccines Sales Volume and Growth Rate
Figure Serum institute of India Private Limited Revenue (Million USD) Market Share 2017-2022
Table Emergent BioSolutions Inc. Profile
Table Emergent BioSolutions Inc. Viral Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent BioSolutions Inc. Viral Vaccines Sales Volume and Growth Rate
Figure Emergent BioSolutions Inc. Revenue (Million USD) Market Share 2017-2022






More Publications